Fierce Pharma

NOVEMBER 27, 2023

After plotting $6 billion in production upgrades earlier this month, Novo Nordisk’s CEO Lars Fruergaard Jørgensen suggested the expansion outlay was just the start. | After plotting $6 billion in production upgrades earlier this month, Novo Nordisk’s CEO Lars Fruergaard Jørgensen suggested the expansion outlay was just the start. Now, some three weeks later, he’s putting his company’s money where his mouth is.

Manufacturing 302

Manufacturing 302

European Pharmaceutical Review

NOVEMBER 27, 2023

Biotech Berlin Cures, a company focusing on neutralising functional autoantibodies (fAABs), is expanding its Phase II clinical trial on Long COVID (post-COVID syndrome). into a pan-European, multi-center collaboration. The study will provide “meaningful and robust results on the efficacy and tolerability” of its lead drug candidate BC 007 in individuals with Long COVID.

Recruitment 130

Recruitment Leads Pharmaceutical Patients 130

Fierce Pharma

NOVEMBER 27, 2023

Eli Lilly’s fortunes have turned quickly. | It was the second straight quarter where the overwhelming success of blood sugar regulating treatments were the dominant story in the biopharma industry. Eli Lilly and Novo Nordisk delivered the highest revenue gains, at 38% and 29%, respectively.

Biopharma 292

Biopharma Pharma 292

Healthcare Success

NOVEMBER 27, 2023

Doctors are central to the success of virtually every multi-location healthcare practice and health system we work with. Moreover, today’s doctor partners have strong opinions about marketing and growing their locations within the larger business. Some of the hospitals and multilocation practices that engage our agency have doctors, executives, investors, and other stakeholders aligned around their brand strategy and marketing plan.

Doctors 118

Doctors Marketing Healthcare Healthcare 118

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Fierce Pharma

NOVEMBER 27, 2023

Following the historic approval of the world’s first CRISPR-based gene-editing therapy in the United Kingdom this month, Vertex Pharmaceuticals has tapped its long-time manufacturing partner Roslin | RoslinCT, the CDMO arm of the Roslin Institute, is set to manufacture Vertex and CRISPR Therapeutics’ exa-cel “across the world” as part of Vertex’s global production network.

Manufacturing 288

Manufacturing Networking Pharmaceutical 288

MedCity News

NOVEMBER 27, 2023

Novo Nordisk’s planned expansion will more than double the footprint of its France production site, bringing new capacity for manfacturing GLP-1 drugs for metabolic conditions. The location is already one of the company’s largest for making diabetes products.

Biopharma 121

Biopharma Pharma 121

PM360

NOVEMBER 27, 2023

Quality in software is a multifaceted concept, closely tied to both conformance to requirements and fit for purpose. In the life sciences industry, where software permeates everything from the drug discovery process to pharmaceutical supply chain management, the need for rigorous fit-for-purpose evaluations has never been more critical. As pharmaceutical regulations increasingly intersect with software development standards, the traditional approach to Computer System Verification (CSV) is falli

Engineering 115

Engineering Medical science Healthcare Provider Healthcare 115

Fierce Pharma

NOVEMBER 27, 2023

Sanofi and Regeneron’s Dupixent has scored in a second phase 3 study in chronic obstructive pulmonary disease (COPD), setting up the monoclonal antibody to become the first biologic to treat the lu | Sanofi and Regeneron’s Dupixent has scored in a second phase 3 study in chronic obstructive pulmonary disease (COPD), setting up the monoclonal antibody to become the first biologic to treat the lung disease and the first advancement in the indication in more than a decade.

191

191

PM360

NOVEMBER 27, 2023

This is the second article in a three-part series examining the commercial dynamics surrounding combination therapy in oncology across the U.S. and Europe. In this article, we investigate strategies that manufacturers could consider to optimize pricing and access opportunities for their combinations in today’s environment. (You can find part one here.

Manufacturing 111

Manufacturing Marketing Competition Patients 111

Fierce Pharma

NOVEMBER 27, 2023

Sponsors, CROs, sites, and anyone else involved in running clinical trials must consider the risk of suicidality. But deep-rooted misconceptions get in the way. | The suicide rate is rising so it’s more important than ever for site staff and principal investigators to assess suicide risk across all trials.

130

130

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

MedCity News

NOVEMBER 27, 2023

One investor is most interested in mental health startups that focus on high acuity care, while another wants to see companies that are built with the end-user in mind, they shared during recent interviews.

112

112

Fierce Pharma

NOVEMBER 27, 2023

THIS IS WHERE THE TEXT OF THE ARTICLE WILL BE. | The introduction that will be displayed in the newsletter.

Training 160

Training 160

PM360

NOVEMBER 27, 2023

Up to now, drug safety teams have relied primarily on reactive reporting systems for pharmacovigilance (PV) or real-world drug safety monitoring. The signals, generally delivered through individual case safety reports (ICSRs), require significant time and effort to uncover, potentially delaying detection and negatively impacting patient safety. Most traditional signal detection methods focus on disproportionality, meanwhile calling attention to higher-than-expected correlations between the suspe

Safety 106

Safety Electronics Patients Physicians 106

pharmaphorum

NOVEMBER 27, 2023

EVERSANA’s alliance with Amazon Web Services (AWS) on the application of generative artificial intelligence (genAI) to the pharma sector has borne its first fruit – a new tool to tackle the time-consuming and error-prone task of getting medical and regulatory content approvals.

Medical 107

Medical Pharma 107

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

PM360

NOVEMBER 27, 2023

I recently sat down with Erica Taylor, PhD, Vice President and Chief Marketing Officer at Genentech, to talk about the future of biopharma marketing and creating more meaningful content. In Erica’s role, she sets the vision, strategic enterprise leadership, and direction for the marketing function at Genentech, covering the company’s full commercial portfolio.

Marketing 105

Marketing Customer Relationship Management Relationship management Education 105

MedCity News

NOVEMBER 27, 2023

At RSNA 2023, healthcare AI startup Paige announced a partnership with Nuance to launch what the companies say is “the largest digital consultation network in pathology.” Paige’s digital pathology tools will be embedded into PowerShare, Nuance’s nationwide image sharing network with the goal of connecting more pathology labs to expert second opinions.

Networking 111

Networking Consulting Healthcare Healthcare 111

PM360

NOVEMBER 27, 2023

Continuing medical education (CME) is a top priority for healthcare providers in order to maintain their medical licensure, broaden and update their clinical knowledge, hone their skills, feed their curiosity, and ensure patients receive the best care and outcomes. Education companies that develop content have a list of considerations to meet when creating learning materials.

Education 105

Education Medical Training Healthcare 105

MedCity News

NOVEMBER 27, 2023

GSK took Blenrep off the market last year after the multiple myeloma drug failed its confirmatory study. But GSK now says it has interim data showing Blenrep beat a blockbuster Johnson & Johnson drug in a head-to-head Phase 3 study testing it as an earlier line of therapy.

Marketing 108

Marketing Biopharma Pharma 108

Advertisement

PM360

NOVEMBER 27, 2023

I started my Insights career at a medical devices division of one of the world’s largest pharmaceutical companies. A significant shake-up at the company marked the start of my tenure: a newly appointed CEO with a consumer-packaged goods (CPG) background introduced a new Chief Marketing Officer (also from CPG) and an influx of global marketers from renowned companies such as P&G, Kraft, and Coca-Cola.

Marketing 104

Marketing Recruitment Patients Manufacturing 104

European Pharmaceutical Review

NOVEMBER 27, 2023

Injecting allogenic neural stem cells into the brains of patients living with progressive multiple sclerosis ( MS ) is safe and well tolerated, a a Phase I trial has shown, with the effects reported to last over 12 months. Findings from the study evaluating the advanced cell therapy treatment for progressive MS have been published in Cell Stem Cell.

Side effects 97

Side effects Specialization Patients Management 97

MedCity News

NOVEMBER 27, 2023

Seniors are mostly still interested in $0 premium Medicare Advantage plans, according to a new eHealth report. However, slightly fewer seniors are choosing these plans compared to previous years.

101

101

PharmaVoice

NOVEMBER 27, 2023

A drug developed by Kinnov Therapeutics halved alcohol consumption in heavy drinkers in a mid-stage study

110

110

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

MedCity News

NOVEMBER 27, 2023

As we navigate the complex terrain of virtual care integration, it is imperative to recognize the significance of payers as catalysts for change.

108

108

Pharmaceutical Technology

NOVEMBER 27, 2023

Olvi-Vec is currently being evaluated in a Phase III trial as a treatment for platinum- resistant/refractory ovarian cancer.

FDA 98

FDA 98

pharmaphorum

NOVEMBER 27, 2023

A year after GSK pulled its BCMA-targeting antibody-drug conjugate (ADC) Blenrep from the US market as a later-line therapy for multiple myeloma, there are signs that the drug may still have a role to play earlier on in the treatment pathway.

Marketing 81

Marketing 81

PharmaTimes

NOVEMBER 27, 2023

The IRP will bring life-saving medicines to UK patients from 1 January 2024 - News - PharmaTimes

Medicine 108

Medicine Patients 108

Advertisement

Distribution

Clarivate

NOVEMBER 27, 2023

A new global survey captures community challenges and views on the future of research A new report from Research Professional TM News, an editorially independent part of Clarivate TM , explores the key priorities, challenges and drivers of change for academic research offices. Based on a global survey of more than 1,600 research office staff and researchers, Research Offices of the Future provides a comprehensive snapshot of the current state of research offices and their relationship with resea

Training 69

Training Government Management 69

PharmaTimes

NOVEMBER 27, 2023

Around £330m will be invested in the software over the next seven years - News - PharmaTimes

Patients 91

Patients 91

pharmaphorum

NOVEMBER 27, 2023

Dupixent aces second COPD study, setting up FDA filing Phil.

FDA 104

FDA 104

Pharmaceutical Technology

NOVEMBER 27, 2023

High-quality monitoring and trial oversight procedures are essential for avoiding the serious consequences that come protocol deviations, poor data quality, and regulatory issues.

52

52

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales